AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · Real-Time Price · USD

4.160

0.00 (0.00%)

At close: Apr 28, 2026, 4:00 PM EDT

4.193

+0.033 (0.80%)

After-hours: Apr 28, 2026, 6:26 PM EDT

AbCellera Biologics Employees

AbCellera Biologics had 562 employees as of December 31, 2025. The number of employees decreased by 34 or -5.70% compared to the previous year.

Employees

562

Change (1Y)

-34

Growth (1Y)

-5.70%

Revenue / Employee

$133,680

Profits / Employee

-$260,520

Market Cap

1.26B

Employees Chart

Date	Employees	Change	Growth
Dec 31, 2025	562	-34	-5.70%
Dec 31, 2024	596	10	1.71%
Dec 31, 2023	586	91	18.38%
Dec 31, 2022	495	109	28.24%
Dec 31, 2021	386	180	87.38%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro

Company Name	Employees
Novavax	749
Pharming Group	407
UroGen Pharma	291
MapLight Therapeutics	133
MoonLake Immunotherapeutics	130
DBV Technologies	117
ArriVent BioPharma	77
GH Research	73